Lucira Health (NASDAQ:LHDX) stock is rocketing higher on Monday thanks to an update from the U.S. Food and Drug Administration (FDA).
The big news here is Lucira Health getting FDA authorization for its at-home combination Covid-19 and flu tests. This will allow consumers to test at home whether they are infected with Covid-19 or the flu.
Lucira Health believes that the speedy results of these tests — less than 30 minutes — and the ability to take them at home will be a game changer. The company envisions a future when going to a doctor for a flu test is a thing of the past.
What About the LHDX Bankruptcy?
Lucira Health is acknowledging that the new approval for its at-home tests comes just a couple of days after a bankruptcy filing. That’s due to the company producing an inventory of its tests for 2022, but then not getting approval in time for that flu season.
Erik Engelson, President and CEO of Lucira Health, said the following on the matter:
“We remain confident in the role that the new test can play in future respiratory seasons and are honored to have received the first authorization for such a home test. We appreciate the diligent work of the FDA team as they refined requirements during the review cycle.”
Investors in LHDX stock will note that the company wants to continue with the production of its at-home tests. This has it seeking out a strategic or financial partner to aid in that effort.
LHDX stock is seeing heavy trading today with some 81 million shares on the move as of this writing. That’s well above its daily average trading volume of about 7 million shares. Shares of the stock are heading 237.1% higher as of Monday morning.
Investors seeking more of the latest stock market news will want to keep reading!
InvestorPlace is home to all of the hottest stock market news traders need to know about. That includes the biggest pre-market stock movers this morning, as well as the latest on the housing market and AI stocks. You can catch up on that at the following links!
More Monday Stock Market News
- Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
- Has the Housing Market Bottomed? This $2.3 Trillion Warning Sign Says Otherwise.
- AI Stocks Are Soaring… But Americans Aren’t That Interested in AI
On Penny Stocks and Low-Volume Stocks: With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That’s because these “penny stocks” are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that InvestorPlace.com’s writers disclose this fact and warn readers of the risks.
Read More: Penny Stocks — How to Profit Without Getting Scammed
On the date of publication, William White did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.